Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes

被引:2
|
作者
Tang Xiaohan [1 ]
Yan Xiang [1 ]
Zhou Houde [1 ]
Huang Gan [1 ]
Niu Xiaohong [10 ]
Jiang Hongwei [10 ]
Su Heng [10 ]
Yang Xilin [21 ]
Li Xia [1 ]
Zhou Zhiguang [1 ]
机构
[1] Department of Endocrinology
[2] Heji Hospital Affiliated to Changzhi Medical College  12. Changzhi  13. Shanxi 046000  1
[3] Department of Metabolism and Endocrinology
[4] Department of Epidemiology and Biostatistics
[5] School of Public Health  23. Tianjin Medical University  24. Tianjin 300070
[6] National Clinical Research Center for Metabolic Diseases  3. Key Laboratory of Diabetes Immunology (Central South University)  4. Ministry of Ed
基金
国家重点研发计划;
关键词
Beta-cell function; Dyslipidemia; Insulin resistance; Type; 1; diabetes; 2;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
Background: Abnormal lipids are strong predictors of cardiovascular disease in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). However, the potential associations of insulin resistance (IR) and beta-cell function (BCF) with abnormal lipids in newly diagnosed T1DM or T2DM patients are not fully understood.Methods: A cross-sectional survey of 15,928 participants was conducted. Homeostasis model assessment and postprandial C-peptide levels were used to estimate IR and BCF. A restricted cubic spline (RCS) nested in binary logistic regression was used to examine the associations of IR and BCF with abnormal lipids.Results: High triglyceride (TG), low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol (LDL-C) accounted for 49.7%, 47.8%, and 59.2% of the participants, respectively. In multivariable analysis, high IR was associated with an increased risk of high TGs (P for trend <0.001) in T1DM and is associated with an elevated risk of high TG and low HDL-C (allP for trend <0.01) in T2DM. Low BCF was not associated with risks of dyslipidemia in patients with T1DM or T2DM after adjustment for potential confounders.Conclusion: High IR had different associations with the risk of dyslipidemia in newly diagnosed T1DM and T2DM patients, suggesting that early treatment that improves IR may benefit abnormal lipid metabolism.
引用
收藏
相关论文
共 50 条
  • [1] Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes
    Tang, Xiaohan
    Yan, Xiang
    Zhou, Houde
    Huang, Gan
    Niu, Xiaohong
    Jiang, Hongwei
    Su, Heng
    Yang, Xilin
    Li, Xia
    Zhou, Zhiguang
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2554 - 2562
  • [2] Insulin resistance and beta-cell deficiency in newly diagnosed type 2 diabetes mellitus
    Bonora, E
    Stoico, V
    Trombetta, M
    Muggeo, M
    Bonadonna, RC
    DIABETES, 2005, 54 : A325 - A325
  • [3] Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
    Tuan Dinh Le
    Nga Thi Phi Nguyen
    Son Tien Nguyen
    Hoa Thi Thanh Tran
    Lan Thi Ho Nguyen
    Hoang Huy Duong
    Ha Manh Nguyen
    Binh Nhu Do
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 2119 - 2127
  • [4] Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)
    Dauriz, Marco
    Trombetta, Maddalena
    Santi, Lorenza
    Boselli, Maria Linda
    Brangani, Corinna
    Pichiri, Isabella
    Travia, Daniela
    Cacciatori, Vittorio
    Negri, Carlo
    Stoico, Vincenzo
    Bonadonna, Riccardo C.
    Bonora, Enzo
    DIABETES, 2017, 66 : A429 - A429
  • [5] Evaluation of insulin resistance and beta-cell dysfunctions in newly diagnosed polycystic ovarian syndrome patients
    Ghatnatti, Vikrant
    Patil, Shwetha
    Kour, Harpreet
    JOURNAL OF THE SCIENTIFIC SOCIETY, 2022, 49 (03) : 260 - 264
  • [6] Insulin resistance and beta-cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10
    Bonora, Enzo
    Trombetta, Maddalena
    Dauriz, Marco
    Brangani, Corinna
    Cacciatori, Vittorio
    Negri, Carlo
    Pichiri, Isabella
    Stoico, Vincenzo
    Rinaldi, Elisabetta
    Da Prato, Giuliana
    Boselli, Maria Linda
    Santi, Lorenza
    Moschetta, Federica
    Zardini, Monica
    Bonadonna, Riccardo C.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (07)
  • [7] The Beta-Cell Function and Glucose Profile of Newly Diagnosed Acromegalic Patients with Normal Glucose Tolerance
    Sun, Quanya
    Li, Xiaoqing
    Chen, Peili
    Chen, Lili
    Zhao, Xiaolong
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
  • [8] Biomarkers for Assessing Beta-Cell Function and Insulin Resistance in Type 2 Diabetes
    Pfuetzner, A.
    Weber, M. M.
    Forst, T.
    DIABETES STOFFWECHSEL UND HERZ, 2008, 17 : S37 - S41
  • [9] Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes
    Kumar, Hemant
    Mishra, Manish
    Bajpai, Surabhi
    Pokhria, Deepa
    Arya, Awadhesh Kumar
    Singh, Rakesh Kumar
    Tripathi, Kamlakar
    ACTA DIABETOLOGICA, 2013, 50 (04) : 511 - 518
  • [10] Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes
    Hemant Kumar
    Manish Mishra
    Surabhi Bajpai
    Deepa Pokhria
    Awadhesh Kumar Arya
    Rakesh Kumar Singh
    Kamlakar Tripathi
    Acta Diabetologica, 2013, 50 : 511 - 518